Search | TVST | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Oral alpha-cyclodextrin targets the gut-retinal axis and corrects diabetic retinopathy (DR) in a mouse model of type 2 diabetes (T2D).

Yvonne Adu-Agyeiwaah; Ram Prasad; Sergio Li Calzi; Bright Asare Bediako; Jason Floyd; Mariana D Dupont; Tim Florian Dorweiler; Cristiano Vieira; Irina A Pikuleva; Julia Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):836.

ARVO Annual Meeting Abstract June 2024

The calvarium bone marrow responds to acute retinal injury and is resilient to chronic diabetes compared to long bone marrow.

Sergio Li Calzi; Bright Asare-Bediako; Ram Prasad; Yvonne Adu-Agyeiwaah; Robert F Rosencrans; Jason Floyd; Denise Stanford; Anna Lin; Todd A Lydic; Michael Boulton; Julia Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):325.

ARVO Annual Meeting Abstract June 2024

Elucidating the role of MEMO1 in EPO-triggered signaling in retinal microvascular endothelial cells

Aniket Ramshekar; Bright Asare-Bediako; Jasmine Nguyen; Arundhathy Suresh; Mary Elizabeth Hartnett

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):291.

ARVO Annual Meeting Abstract June 2024

Short-term selective activation of phospho-Y1175 (p-Y1175) on VEGFR2 suppresses retinal endothelial cell migration

Bright Asare-Bediako; Aniket Ramshekar; Jasmine Nguyen; Arundhathy Suresh; Mary Elizabeth Hartnett

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2197.

ARVO Annual Meeting Abstract June 2023

LP-ACE2 attenuates diabetic visual impairment by improving gut barrier integrity and intestinal lymphatics in type 1 diabetes

Ram Prasad; Jason Floyd; Yvonne Adu-Agyeiwaah; Bright Asare-Bediako; Sergio Li Calzi; Dibyendu Chakraborty; Angela Harbour; Aayush Rohella; Irina A Pikuleva; Julia V. Busik; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):938.

ARVO Annual Meeting Abstract June 2023

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D).

Yvonne Adu-Agyeiwaah; Bright Asare-Bediako; Jason Floyd; Mariana D DuPont; Cristiano Vieira; Ram Prasad; Sergio Li Calzi; Irina A Pikuleva; Julia V. Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1834.

ARVO Annual Meeting Abstract June 2023

Calvarium bone marrow is the source of bone marrow-derived cells that migrate into the injured retina

Sergio Li Calzi; Bright Asare-Bediako; Yvonne Adu-Agyeiwaah; Ram Prasad; Julia V. Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3866.

Retina April 2023

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes

PDF

Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sergio Li Calzi; Mariana DuPont; Jason Floyd; Sanford Boye; Vince Chiodo; Julia V. Busik; Maria B. Grant
TAGS: diabetes mellitus, diabetes mellitus, type 2, diabetic retinopathy, intravitreal injections, mice, retina, blood capillaries, inflammation, hypoxia
Trans. Vis. Sci. Tech.. 2023; 12(4):20. https://doi.org/10.1167/tvst.12.4.20

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2022

Intravitreal administration of AAV2-SIRT1 reverses diabetic retinopathy (DR) in a murine model of type 2 diabetes (T2D)

Maria B Grant; Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sandra S Hammer; Sergio Li Calzi; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2310.

ARVO Annual Meeting Abstract June 2022

Maintenance of intestinal ACE2 minimizes the risk of developing diabetic retinopathy in type 1 diabetes

Ram Prasad; Jason Floyd; Bright Asare-Bediako; Dibyendu Chakraborty; Yvonne Adu-Agyeiwaah; Angela Harbour; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2309.

ARVO Annual Meeting Abstract June 2022

DIFFERENTIAL RECUITMENT OF HEMATOPOIETIC CELLS INTO THE INJURED RPE/CHOROID

Bright Asare-Bediako; Sergio Li Calzi; Yvonne Adu-Agyeiwaah; Jason Floyd; Mariana D DuPont; Maria Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3025 – F0396.

ARVO Annual Meeting Abstract June 2022

Oral administration of alpha-cyclodextrin reverses diabetic retinopathy in db/db mice

Yvonne Adu-Agyeiwaah; Sandra S Hammer; Cristiano P. Vieira; Bright Asare-Bediako; Jason Floyd; Mariana D DuPont; Ram Prasad; Sergio Li Calzi; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3591 – A0046.

ARVO Annual Meeting Abstract June 2021

Physiological Recruitment of Hematopoietic Cells and Innervation in the Developing Retina

Bright Asare-Bediako; Chao Huang; Cristiano P. Vieira; Yvonne Adu-Agyeiwaah; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1698.

ARVO Annual Meeting Abstract June 2021

Intravitreal AAV2-SIRT1 administration reverses diabetic retinopathy in db/db mice

Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sandra S Hammer; Sergio Li Calzi; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1106.

ARVO Annual Meeting Abstract June 2020

Oral administration of engineered probiotic prevents gut dysbiosis in type 1 diabetes and alleviates diabetic retinopathy (DR)

Ram Prasad; Jason L. Floyd; DIBYENDU CHAKRABORTY; Bright Asare-Bediako; Yvonne Adu-Agyeiwaah; Sergio Li Calzi; Robert F. Rosencrans; Chao Huang; Mariana DuPont; Sunil K Noothi; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1169.

ARVO Annual Meeting Abstract June 2020

LXR activation prevents development of diabetic retinopathy (DR) in db/db mice by controlling cholesterol and stem cell profiles

Yvonne Adu-Agyeiwaah; Cristiano P Vieira; Ana Leda Longhini; Bright Asare-Bediako; Micheli Sielski; Mariana DuPont; Sergio Li Calzi; Julia Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5161.

ARVO Annual Meeting Abstract July 2019

A PLGA-Carboxyamidotriazole (CAI) Polymeric Suspension Suppresses Pathological Ocular Angiogenesis in rodent CNV model.

Sergio Li Calzi; DIBYENDU CHAKRABORTY; Bright Asare-Bediako; Isabel Franklin; Srikanth Kakumanu; Laurent Balenci; Maria B Grant; Alan Franklin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5411.

ARVO Annual Meeting Abstract July 2019

In Vivo Retinal Structural Lesions, Functional Deficits and Peripheral Blood Cell phenotype in Mice with High-Fat Diet-Induced Retinopathy

Bright Asare-Bediako; Sunil Nooti; Sergio Li Calzi; Baskaran Athmanathan; Cristiano Pedrozo Vieira; Ana Leda Figueiredo Longhini; Mariana Dupont; DIBYENDU CHAKRABORTY; Prabhakara R Nagareddy; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2688.

ARVO Annual Meeting Abstract July 2019

Targeting LXR using N,N-dimethyl-3ß-hydroxycholenamide (DMHCA) provides protection from development of diabetic retinopathy in db/db mice

Cristiano Pedrozo Vieira; Ana Leda Figueiredo Longhini; Sergio L Calzi; Bright Asare-Bediako; Mariana Dupont; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2788.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Oral alpha-cyclodextrin targets the gut-retinal axis and corrects diabetic retinopathy (DR) in a mouse model of type 2 diabetes (T2D).

The calvarium bone marrow responds to acute retinal injury and is resilient to chronic diabetes compared to long bone marrow.

Elucidating the role of MEMO1 in EPO-triggered signaling in retinal microvascular endothelial cells

Short-term selective activation of phospho-Y1175 (p-Y1175) on VEGFR2 suppresses retinal endothelial cell migration

LP-ACE2 attenuates diabetic visual impairment by improving gut barrier integrity and intestinal lymphatics in type 1 diabetes

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D).

Calvarium bone marrow is the source of bone marrow-derived cells that migrate into the injured retina

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes

Intravitreal administration of AAV2-SIRT1 reverses diabetic retinopathy (DR) in a murine model of type 2 diabetes (T2D)

Maintenance of intestinal ACE2 minimizes the risk of developing diabetic retinopathy in type 1 diabetes

DIFFERENTIAL RECUITMENT OF HEMATOPOIETIC CELLS INTO THE INJURED RPE/CHOROID

Oral administration of alpha-cyclodextrin reverses diabetic retinopathy in db/db mice

Physiological Recruitment of Hematopoietic Cells and Innervation in the Developing Retina

Intravitreal AAV2-SIRT1 administration reverses diabetic retinopathy in db/db mice

Oral administration of engineered probiotic prevents gut dysbiosis in type 1 diabetes and alleviates diabetic retinopathy (DR)

LXR activation prevents development of diabetic retinopathy (DR) in db/db mice by controlling cholesterol and stem cell profiles

A PLGA-Carboxyamidotriazole (CAI) Polymeric Suspension Suppresses Pathological Ocular Angiogenesis in rodent CNV model.

In Vivo Retinal Structural Lesions, Functional Deficits and Peripheral Blood Cell phenotype in Mice with High-Fat Diet-Induced Retinopathy

Targeting LXR using N,N-dimethyl-3ß-hydroxycholenamide (DMHCA) provides protection from development of diabetic retinopathy in db/db mice

To View More...

You must be signed into an individual account to use this feature.